ARTICLE | Clinical News
Architect AFP regulatory update
April 8, 2013 7:00 AM UTC
FDA approved Abbott's Architect AFP test as an aid in monitoring disease progression in patients with nonseminomatous testicular cancer and an aid in detecting fetal open neural tube defects (NTD). Th...